The Ability of Rodent Islet Amyloid Polypeptide To Inhibit Amyloid Formation by Human Islet Amyloid Polypeptide Has Important Implications for the Mechanism of Amyloid Formation and the Design of Inhibitors
- 22 December 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 49 (5), 872-881
- https://doi.org/10.1021/bi901751b
Abstract
Islet amyloid polypeptide (IAPP) is a 37-residue polypeptide hormone that is responsible for islet amyloid formation in type II diabetes. Human IAPP is extremely amyloidogenic, while rat IAPP and mouse IAPP do not form amyloid in vitro or in vivo. Rat IAPP and mouse IAPP have identical primary sequences, but differ from the human polypeptide at six positions, five of which are localized between residues 20 and 29. The ability of rat IAPP to inhibit amyloid formation by human IAPP was tested, and the rat peptide was found to be an effective inhibitor. Thioflavin-T fluorescence-monitored kinetic experiments, transmission electron microscopy, and circular dichroism showed that rat IAPP lengthened the lag phase for amyloid formation by human IAPP, slowed the growth rate, reduced the amount of amyloid fibrils produced in a dose-dependent manner, and altered the morphology of the fibrils. The inhibition of human IAPP amyloid formation by rat IAPP can be rationalized by a model that postulates formation of an early helical intermediate during amyloid formation where the helical region is localized to the N-terminal region of IAPP. The model predicts that proline mutations in the putative helical region should lead to ineffective inhibitors as should mutations that alter the peptide−peptide interaction interface. We confirmed this by testing the ability of A13P and F15D point mutants of rat IAPP to inhibit amyloid formation by human IAPP. Both these mutants were noticeably less effective inhibitors than wild-type rat IAPP. The implications for inhibitor design are discussed.Keywords
This publication has 59 references indexed in Scilit:
- Helix Stabilization Precedes Aqueous and Bilayer-Catalyzed Fiber Formation in Islet Amyloid PolypeptideJournal of Molecular Biology, 2009
- Animal models of human amyloidoses: Are transgenic mice worth the time and trouble?FEBS Letters, 2009
- A critical assessment of the role of helical intermediates in amyloid formation by natively unfolded proteins and polypeptidesProtein Engineering, Design and Selection, 2009
- Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the processProtein Science, 2009
- A role for helical intermediates in amyloid formation by natively unfolded polypeptides?Physical Biology, 2009
- Structures of Rat and Human Islet Amyloid Polypeptide IAPP1−19 in Micelles by NMR SpectroscopyBiochemistry, 2008
- Amylin Proprotein Processing Generates Progressively More Amyloidogenic Peptides that Initially Sample the Helical StateBiochemistry, 2008
- Structure of α-Helical Membrane-bound Human Islet Amyloid Polypeptide and Its Implications for Membrane-mediated MisfoldingPublished by Elsevier BV ,2008
- Direct detection of transient α‐helical states in islet amyloid polypeptideProtein Science, 2007
- Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseasesNature, 2004